Please Note: This trial is no longer enrolling new participants
A Phase 3, Randomized, Double-Blind Study of Pembrolizumab versus Placebo in Combination With Adjuvant Chemotherapy With or Without Radiotherapy for the Treatment of Newly Diagnosed High-Risk Endometrial Cancer After Surgery With Curative Intent (KEYNOTE-B21 / ENGOT-en11 / GOG-3053).
Protocol No. | CTO-GOG-3053 | Scope | National |
---|---|---|---|
Principal Investigator | Lisa Landrum | Treatment Type | Treatment |
Age Group | Adult | Phase | Phase III |